Oncology Therapeutics
NUVATION BIO: Products & infrastructure
NUVATION BIO has 19 clinical trials on record, 9 under way.
Data updated Nov 20, 2026 · Back to the company report
Products
NUVATION BIO has 19 clinical trials on record, 9 under way.
19clinical trials
9trials under way
4in phase 3
2EU trials (CTIS)
EU clinical trialsthe trials it sponsors, per the EU's CTIS register
A Phase 3 Multicenter Double-blind Randomized Study of Taletrectinib Versus Placebo in Patients With ROS1-Fusion Positi…
Therapeutic confirmatory (Phase III) · Non Small Cell Lung Cancer (NSCLC) · Spain, Belgium, France, Italy, Germany
Jun 2026
A Single-Arm, Open-Label, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of Taletrectinib in Patients wi…
Therapeutic exploratory (Phase II) · Non-small Cell Lung Cancer · Italy, Spain, Poland, France
Oct 2024
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov · and 11 more records
Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment…
phase 2 · under way · 40 participants · Grade 2 IDH1-mutant Glioma; Grade 3 IDH1-mutant Glioma; Glioma; IDH1-mutant Gli…
Mar 2027
Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma
phase 3 · under way · 140 participants · Grade 2 Glioma (Astrocytoma or Oligodendroglioma) With an IDH1 Mutation; Astroc…
Mar 2027
Study on the Effect of Famotidine on Pharmacokinetics of Taletrectinib
phase 1 · under way · 56 participants · Healthy Adult Participants
Aug 2026
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
phase 3 · under way · 180 participants · Non-small Cell Lung Cancer (NSCLC)
Aug 2025
A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-sma…
phase 3 · under way · 194 participants · Non Small Cell Lung Cancer
Nov 2024
Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors
phase 2 · under way · 466 participants · Advanced Solid Tumor; HER2-negative Breast Cancer; Metastatic Castration-resist…
Mar 2024
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
phase 3 · under way · 365 participants · Glioma; Astrocytoma, Grade IV; IDH1-mutant Glioma; Astrocytoma, IDH-Mutant, Gra…
Jun 2023
Study the Effect of Omeprazole on AB-106 Pharmacokinetics
phase 1 · completed · 24 participants · Pharmacokinetic Study
Nov 2022
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
